Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Leukemia|April 27, 2013
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapyS E M Herman, X Sun, E M McAuley, et al.
Blood|August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patientsBetty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignanciesRanjana H Advani, Joseph J Buggy, Jeff P Sharman, et al.
Molecular Cancer Therapeutics|August 8, 2006
CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivoZ Alexander Cao, Kathryn E Bass, Sriram Balasubramanian, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2012
The impact of age and gender on papillary thyroid cancer survivalJ Jonklaas, G Nogueras-Gonzalez, M Munsell, et al.
Npj Drug Discovery|July 1, 2026
Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunityLih-Yun Hsu, James T Rosenbaum, Erik Verner, et al.
Journal of Opioid Management|October 29, 2021
Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC)Sohan Lal Solanki, Raghu S Thota, Jeson Rajan, et al.
Blood|December 7, 2013
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)Jennifer A Woyach, Engin Bojnik, Amy S Ruppert, et al.
Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Pageof 21